Logo image of ORKT

ORANGEKLOUD TECHNOLOGY INC (ORKT) Stock Fundamental Analysis

NASDAQ:ORKT - KYG6781F1019 - Common Stock

0.7369 USD
+0.02 (+3.06%)
Last: 8/22/2025, 7:33:06 PM
0.737 USD
+0 (+0.01%)
After Hours: 8/22/2025, 7:33:06 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ORKT. ORKT was compared to 83 industry peers in the IT Services industry. The financial health of ORKT is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ORKT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ORKT has reported negative net income.
ORKT had a negative operating cash flow in the past year.
ORKT Yearly Net Income VS EBIT VS OCF VS FCFORKT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -62.36%, ORKT is not doing good in the industry: 90.36% of the companies in the same industry are doing better.
With a Return On Equity value of -73.69%, ORKT is not doing good in the industry: 81.93% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -62.36%
ROE -73.69%
ROIC N/A
ROA(3y)-18.46%
ROA(5y)N/A
ROE(3y)-22.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ORKT Yearly ROA, ROE, ROICORKT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

The Gross Margin of ORKT (26.36%) is worse than 68.67% of its industry peers.
In the last couple of years the Gross Margin of ORKT has declined.
ORKT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.59%
GM growth 5YN/A
ORKT Yearly Profit, Operating, Gross MarginsORKT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

6

2. Health

2.1 Basic Checks

ORKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ORKT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ORKT has an improved debt to assets ratio.
ORKT Yearly Shares OutstandingORKT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
ORKT Yearly Total Debt VS Total AssetsORKT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

ORKT has an Altman-Z score of 3.71. This indicates that ORKT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ORKT (3.71) is better than 63.86% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that ORKT is not too dependend on debt financing.
ORKT's Debt to Equity ratio of 0.02 is amongst the best of the industry. ORKT outperforms 80.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 3.71
ROIC/WACCN/A
WACC8.99%
ORKT Yearly LT Debt VS Equity VS FCFORKT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

ORKT has a Current Ratio of 5.98. This indicates that ORKT is financially healthy and has no problem in meeting its short term obligations.
ORKT has a Current ratio of 5.98. This is amongst the best in the industry. ORKT outperforms 91.57% of its industry peers.
A Quick Ratio of 5.98 indicates that ORKT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.98, ORKT belongs to the best of the industry, outperforming 91.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.98
Quick Ratio 5.98
ORKT Yearly Current Assets VS Current LiabilitesORKT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

ORKT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -375.46%.
The Revenue for ORKT has decreased by -31.66% in the past year. This is quite bad
ORKT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.29% yearly.
EPS 1Y (TTM)-375.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-602.78%
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y-6.29%
Revenue growth 5YN/A
Sales Q2Q%-76.78%

3.2 Future

The Earnings Per Share is expected to grow by 22.48% on average over the next years. This is a very strong growth
ORKT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.74% yearly.
EPS Next Y-179.99%
EPS Next 2Y22.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.14%
Revenue Next 2Y20.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ORKT Yearly Revenue VS EstimatesORKT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2M 4M 6M
ORKT Yearly EPS VS EstimatesORKT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ORKT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ORKT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ORKT Price Earnings VS Forward Price EarningsORKT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ORKT Per share dataORKT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

ORKT's earnings are expected to grow with 22.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.48%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ORKT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORANGEKLOUD TECHNOLOGY INC

NASDAQ:ORKT (8/22/2025, 7:33:06 PM)

After market: 0.737 +0 (+0.01%)

0.7369

+0.02 (+3.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-02 2025-05-02/dmh
Earnings (Next)N/A N/A
Inst Owners1.2%
Inst Owner ChangeN/A
Ins Owners7.15%
Ins Owner ChangeN/A
Market Cap17.21M
Analysts82.86
Price Target5.1 (592.09%)
Short Float %1.8%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.61
P/FCF N/A
P/OCF N/A
P/B 1.64
P/tB 1.88
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.2
BVpS0.45
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.36%
ROE -73.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.36%
FCFM N/A
ROA(3y)-18.46%
ROA(5y)N/A
ROE(3y)-22.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.59%
GM growth 5YN/A
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 156.35%
Cap/Sales 7.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.98
Quick Ratio 5.98
Altman-Z 3.71
F-Score3
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)132.74%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-375.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-602.78%
EPS Next Y-179.99%
EPS Next 2Y22.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y-6.29%
Revenue growth 5YN/A
Sales Q2Q%-76.78%
Revenue Next Year4.14%
Revenue Next 2Y20.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-518.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-101.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-867.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-884.15%
OCF growth 3YN/A
OCF growth 5YN/A